9EOI image
Deposition Date 2024-03-14
Release Date 2025-02-19
Last Version Date 2025-02-19
Entry Detail
PDB ID:
9EOI
Keywords:
Title:
Crystal structure of the GH19 endolysin from Pseudomonas aeruginosa
Biological Source:
Source Organism(s):
Expression System(s):
Method Details:
Experimental Method:
Resolution:
1.77 Å
R-Value Free:
0.25
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Putative lytic enzyme
Chain IDs:A, B
Chain Length:209
Number of Molecules:2
Biological Source:Pseudomonas aeruginosa UCBPP-PA14
Ligand Molecules
Primary Citation
Pseudomonas aeruginosa Cryptic Prophage Endolysin Is a Highly Active Muramidase.
Biochemistry 64 3446 3458 (2025)
PMID: 40631624 DOI: 10.1021/acs.biochem.5c00142

Abstact

Endolysins are phage-encoded enzymes that cleave the peptidoglycan of host bacteria. These enzymes have gained considerable attention due to their ability to cause cell lysis, making them candidates as antibacterial agents. Most Pseudomonas aeruginosa genomes, including the common laboratory strains PAO1 and UCBPP-PA14, contain a cryptic prophage encoding a glycoside hydrolase family 19 endolysin (named PaGH19Lys in the present study). Family 19 glycoside hydrolases are known to target peptidoglycan and chitin-type substrates. PaGH19Lys was not active toward chitin but exhibited activity toward chloroform-treated Gram-negative bacteria, displaying ∼10,000-fold higher activity than hen egg white lysozyme. Analysis of products derived from PaGH19Lys activity toward purified P. aeruginosa peptidoglycan showed that the enzyme catalyzed hydrolysis of the β-1,4 linkage between N-acetylmuramic acid and N-acetyl-d-glucosamine, classifying the enzyme as a muramidase. Finally, the crystal structure of PaGH19Lys was determined and solved to 1.8 Å resolution. The structure of the enzyme showed a globular α-helical fold possessing a deep but relatively open catalytic cleft.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback